MADELINE L SINGER

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neuromuscular Medicine PORTLAND, OR NPI 1013369131

General Payments — all program years on this page

$2,978.11

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 28
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,851.99 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $964.4914
Consulting Fee $887.501

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $544.607
2023 $581.526
2024 $1,851.9915

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078857194 Janssen Scientific Affairs, LLC $887.50 10/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078857268 Janssen Scientific Affairs, LLC $16.25 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104815121 Biogen, Inc. $11.11 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104849470 Biogen, Inc. $138.19 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125846830 Alnylam Pharmaceuticals Inc. $89.68 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137676999 Takeda Pharmaceuticals U.S.A., Inc. $100.18 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137677001 Takeda Pharmaceuticals U.S.A., Inc. $115.63 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137677003 Takeda Pharmaceuticals U.S.A., Inc. $14.74 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139939581 GENZYME CORPORATION $38.36 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139939633 GENZYME CORPORATION $124.00 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139939671 GENZYME CORPORATION $66.42 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142118420 ARGENX US, INC. $62.11 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142119739 ARGENX US, INC. $83.33 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142121179 ARGENX US, INC. $3.01 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143033503 UCB, Inc. $101.48 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.